News
Adam Kovalčík, a 19-year-old from Slovakia, secured a top prize at an international science competition. He developed a ...
AI has become a critical tool in diagnosing and managing viral infections such as influenza, respiratory syncytial virus (RSV ...
14d
Sportschosun on MSNCOVID-19 Cases Doubles Over 4 Weeks...Medical Association's Personal Hygiene Compliance Request
The Korean Medical Association's Infectious Disease Response Committee (hereinafter referred to as the Committee) recently ...
New stem cell therapy has shown effective in boosting immune recovery for cats with feline infectious peritonitis.
A Fallen Giant Pfizer (NYSE:PFE) has been a bitter pill for investors to swallow. Down 19% from its 52-week high of $30.43 per share, PFE stock has plummeted over 50% in the past three years, a stark ...
Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...
Pfizer (PFE) increased its 2025 profit outlook by 10 cents a share to a range of $2.90 to $3.10 a share, citing continued cost cuts, a lower tax rate and "confidence" that strength seen in the first ...
3d
The Cool Down on MSNTeen scientist makes stunning breakthrough that could slash costs of lifesaving drugs: 'I cannot describe this feeling'
At this year's Regeneron International Science and Engineering Fair in Columbus, judges awarded the George D. Yancopoulos Innovator Award to Kovalčík, whose drug production method — as Business ...
From medicines from snake venom to supercrops and plastic-eating enzymes. Nine researchers from Leiden University will receive Open Competition XS ...
Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...
7d
GlobalData on MSNPfizer shares rise 3% after upping profit forecast for 2025
Pfizer bucked the trend of a tepid big pharma Q2 window, raising its full-year profit forecast on the back of strong sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results